Anna Lokshin

9.5k citations
137 papers · 6.7k indexed · h-index 48

Impact in

    • Ovarian cancer diagnosis and treatment
  • Oncology top 1%
    • Cancer Cells and Metastasis
    • Pancreatic and Hepatic Oncology Research
    • Cancer Immunotherapy and Biomarkers

Papers in

    • Ovarian cancer diagnosis and treatment 24
    • Pancreatic and Hepatic Oncology Research 12
    • Chemokine receptors and signaling 10
    • Cytokine Signaling Pathways and Interactions 7

Anna Lokshin

136 papers receiving 6.6k citations

Peers

Anna Lokshin
Comparison fields: 5 of 142
  • Reproductive Medicine 1.1k
  • Oncology 2.4k
  • Immunology 1.7k
  • Cancer Research 1.1k
  • Obstetrics and Gynecology 408
Replace John S. Coon with:
John S. Coon United States
Olaf Ortmann Germany
Kiyosumi Shibata Japan
Shigehiko Mizutani Japan
Santo V. Nicosia United States
Hidemichi Watari Japan
Efthimios Sivridis Greece
Takuya Moriya Japan
Stefania Staibano Italy
J. Engel Germany
Anna Lokshin relative to John S. Coon United States John S. Coon's profile →
Citations per field
00.5×2.7×
John S. Coon · 1×
Citations per year

Countries citing papers authored by Anna Lokshin

Since Specialization
Citations

This map shows the geographic impact of Anna Lokshin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Lokshin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Lokshin more than expected).

Fields of papers citing papers by Anna Lokshin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Lokshin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Lokshin. The network helps show where Anna Lokshin may publish in the future.

Co-authors

The 25 scholars most cited alongside Anna Lokshin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anna Lokshin Line = papers co-authored together Anna Lokshin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 202210
2 20212
3 201621
4 201538
5 201432
6 201411
7 20148
8 201262
9 201278
10 2011186
11 201025
12 2009124
13 200975
14 200931
15 200945
16 200955
17 2008347
18
Multimarker assay for early diagnosis of ovarian cancer
20063
19 2006113
20 199613

About Anna Lokshin

Anna Lokshin is a scholar working on Reproductive Medicine, Oncology, Obstetrics and Gynecology, Immunology and Cancer Research, having authored 137 papers that have together received 6.7k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (24 papers), Endometrial and Cervical Cancer Treatments (15 papers), Immunotherapy and Immune Responses (15 papers), Pancreatic and Hepatic Oncology Research (12 papers), Immune Cell Function and Interaction (11 papers), Chemokine receptors and signaling (10 papers), Adipokines, Inflammation, and Metabolic Diseases (8 papers) and Cytokine Signaling Pathways and Interactions (7 papers). The work is most often cited by research in Reproductive Medicine (1.1k citations), Oncology (2.4k citations), Immunology (1.7k citations), Cancer Research (1.1k citations) and Obstetrics and Gynecology (408 citations). Anna Lokshin has collaborated with scholars based in United States, Japan and Canada. Frequent co-authors include Elieser Gorelik, Adele Marrangoni, Brian M. Nolen, Vera Levina, Zoya R. Yurkovetsky, Robert C. Bast, Lyudmila Velikokhatnaya, Michael R. Shurin, Richard DeMarco and Matthew Winans. Their work appears in journals such as Cancer Research, Gynecologic Oncology, Clinical Cancer Research, Cancer Epidemiology Biomarkers & Prevention and Cancer Biomarkers.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026